General Information of Drug (ID: DR1367)
Drug Name
Propranolol hydrochloride
Synonyms
Panolol; Prandol; Pronovan; Propabloc; Propadex; Propalong; Propayerst; Proprahexal; Propral; Propranolol Hcl; Propranolol chloride; Propranolol hydrochloride; Propranovitan; Pylapron; Rapynogen; Scandrug; Sloprolol; Sudenol; Tiperal; (+)-1-Isopropylamino-3-(1-naphthyloxy)-2-propanol; (+)-Propranolol; (2R)-1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol; (R)-(+)-propranolol; (R)-Propranolol; 2-Propanol, 1-(isopropylamino)-3-(1-naphthyloxy)-, (+)-; 2R-Propranolol; 5051-22-9; CHEBI:8736; D-Propranolol; DEXPROPRANOLOL; Despropranolo [DCIT]; Dexpropranolol [INN:BAN]; Dexpropranololum; Dexpropranololum [INN-Latin]; Dextropropranolol; EINECS 225-749-2; NCGC00016429-05; PG6KY07UD7; R (+)-Propanolol; R-(+)-Propranolol; UNII-PG6KY07UD7; 318-98-9; Anaprilin; Apsolol; Arcablock; Artensol; Beprane; Berkolol; Beta Neg; Cardinol; Caridolol; Corbeta; Detensol; Dibudinate; Duranol; Efectolol; Emforal; Frekven; Hemipralon; Herzbase; Ikopal; Inderal; Inderalici; Inderex; Indermigran; Indobloc; InnoPran XL; Kemi; Kidoral; Naprilin; Nelderal; Noloten; Novopranol
Indication Migraine [ICD11: 8A80] Approved [1]
Structure
3D MOL is unavailable 2D MOL
Pharmaceutical Properties Molecular Weight 295.8 Topological Polar Surface Area 41.5
Heavy Atom Count 20 Rotatable Bond Count 6
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 3
Cross-matching ID
PubChem CID
62882
ChEBI ID
CHEBI:8500
CAS Number
318-98-9
TTD Drug ID
D04JEE
Formula
C16H22ClNO2
Canonical SMILES
CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl
InChI
1S/C16H21NO2.ClH/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16;/h3-9,12,14,17-18H,10-11H2,1-2H3;1H
InChIKey
ZMRUPTIKESYGQW-UHFFFAOYSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
1-Naphthol DM003016
7005
Unclear 1 [9]
4'-hydroxypropanolol DM003017
91565
Oxidation - 4-Hydroxylation 1 [10] , [11]
Alpha-Naphthoxylactic Acid DM003020
115274
Oxidation - Oxidation 1 [12]
N-desisopropylpropranolol DM003014
159899
Oxidation - N-Desisopropylation 1 [11]
Propranolol glucuronide DM003015
119515
Conjugation - O-Glucuronidation 1 [12]
4-hydroxyalprenolol glucuronide DM003018
129823
Conjugation - Glucuronidation 2 [10] , [11]
metaboliteVI DM003021
76313
Unclear 2 [9]
Naphthalene-1,4-diol DM003019
11305
Unclear 2 [9]
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR002192 Propranolol hydrochloride N-desisopropylpropranolol Oxidation - N-Desisopropylation CYP1A2 [11]
MR002193 Propranolol hydrochloride Propranolol glucuronide Conjugation - O-Glucuronidation Unclear [12]
MR002194 Propranolol hydrochloride 1-Naphthol Unclear Unclear [9]
MR002195 Propranolol hydrochloride 4'-hydroxypropanolol Oxidation - 4-Hydroxylation CYP2D6 [10], [11]
MR002196 Propranolol hydrochloride Alpha-Naphthoxylactic Acid Oxidation - Oxidation Unclear [12]
MR002189 4'-hydroxypropanolol 4-hydroxyalprenolol glucuronide Conjugation - Glucuronidation Unclear [10], [11]
MR002190 4'-hydroxypropanolol Naphthalene-1,4-diol Unclear Unclear [9]
MR002191 Alpha-Naphthoxylactic Acid metaboliteVI Unclear Unclear [9]
⏷ Show the Full List of 8 MR(s)
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Cytochrome P450 102A1 (cyp102) DME1075 Bacillus megaterium
CPXB_BACMB
1.14.14.1
[2]
Cytochrome P450 1A2 (CYP1A2) DME0003 Homo sapiens
CP1A2_HUMAN
1.14.14.1
[3]
Cytochrome P450 2D6 (CYP2D6) DME0009 Homo sapiens
CP2D6_HUMAN
1.14.14.1
[4]
Cytochrome P450 3A4 (CYP3A4) DME0001 Homo sapiens
CP3A4_HUMAN
1.14.14.55
[5]
Cytochrome P450 3A5 (CYP3A5) DME0012 Homo sapiens
CP3A5_HUMAN
1.14.14.1
[6]
Cytochrome P450 3A7 (CYP3A7) DME0015 Homo sapiens
CP3A7_HUMAN
1.14.14.1
[6]
Dimethylaniline oxidase 2 (FMO2) DME0283 Homo sapiens
FMO2_HUMAN
1.14.13.8
[7]
Mephenytoin 4-hydroxylase (CYP2C19) DME0021 Homo sapiens
CP2CJ_HUMAN
1.14.14.1
[8]
⏷ Show the Full List of 8  DME(s)
References
1 Propranolol Hydrochloride was approved by FDA. The 2020 official website of the U.S. Food and Drug Administration.
2 acillus megaterium SF185 spores exert protective effects against oxidative stress in vivo and in vitro. Sci Rep. 2019 Aug 19;9(1):12082.
3 Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218.
4 Structure-activity relationship for human cytochrome P450 substrates and inhibitors. Drug Metab Rev. 2002 Feb-May;34(1-2):69-82.
5 Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase. Drug Metab Dispos. 1994 Nov-Dec;22(6):909-15.
6 The influence of diltiazem versus cimetidine on propranolol metabolism. J Clin Pharmacol. 1992 Dec;32(12):1099-104.
7 Human FMO2-based microbial whole-cell catalysts for drug metabolite synthesis. Microb Cell Fact. 2015 Jun 12;14:82.
8 Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br J Clin Pharmacol. 2001 Oct;52(4):349-55.
9 Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites J Pharmacol Exp Ther. 1972 Jul;182(1):83-92.
10 Isolation, purification, and structure identification of glucuronic acid conjugates of propranolol and alprenolol and their ring-hydroxylated metabolites Drug Metab Dispos. 1984 Nov-Dec;12(6):749-54.
11 Rapid and simultaneous extraction of propranolol, its neutral and basic metabolites from plasma and assay by high-performance liquid chromatography J Chromatogr. 1985 Oct 11;343(2):349-58. doi: 10.1016/s0378-4347(00)84603-4.
12 Propranolol metabolism in normal subjects: association with sex steroid hormones Clin Pharmacol Ther. 1994 Aug;56(2):127-32. doi: 10.1038/clpt.1994.115.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.